Related Experiment Video
Updated: Jan 29, 2026

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Unbiased Characterization of Atrial Fibrillation Phenotypic Architecture Provides Insight Into Genetic Liability and
Giovanni Davogustto1, Shilin Zhao2, Yajing Li3
1Division of Cardiovascular Medicine, Department of Medicine (G.D., E.F.-E., B.D.L., L.L.S., M.B.S., D.M.R., Q.S.W.), Vanderbilt University Medical Center, Nashville, TN.
Machine learning identified atrial fibrillation (AF) subgroups based on comorbidities. These AF patient clusters showed varied risks for outcomes and differing polygenic liability to AF and inflammation.
Area of Science:
- Cardiology
- Genetics
- Computational Biology
Background:
- Atrial fibrillation (AF) is a common arrhythmia with unclear underlying mechanisms and clinical heterogeneity.
- Machine learning can identify data-driven disease subtypes, but their clinical relevance in AF is not well-established.
Purpose of the Study:
- To identify distinct atrial fibrillation (AF) phenotypic clusters using machine learning.
- To investigate the association of these AF clusters with polygenic liability, inflammation, and clinical outcomes.
Main Methods:
- Applied unsupervised coclustering machine learning to 35 clinical features in 23,271 individuals with AF.
- Assessed clinical inflammation using biomarkers and genetic liability using polygenic risk scores for AF and cytokine levels.
- Analyzed associations with mortality, stroke, bleeding, and device use.
Main Results:
- Identified 3 AF phenotypic clusters characterized by increasing comorbidity burden (renal disease, coronary artery disease).
- The low comorbidity cluster had the highest polygenic liability to AF, while the high comorbidity cluster showed elevated clinical inflammation.
- Cluster assignment was significantly associated with mortality, stroke, bleeding, and cardiac device implantation.
Conclusions:
- AF patient subgroups identified by clustering differ in comorbidity burden, clinical inflammation, and polygenic liability to AF.
- These AF clusters are associated with distinct risks for clinical outcomes.
- Comorbidity and genetic liability are key drivers of AF phenotypic variability.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Clinically Relevant Drug Product Specifications: Methods of Establishment
What is Population Genetics?
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Predicting Reaction Outcomes

